#USA #New York #Tradr ETFs #Tempus AI #Leveraged ETF

Tradr ETFs Launches First Leveraged ETF on Tempus AI

In a significant move for sophisticated investors and traders, Tradr ETFs has announced the launch of its new leveraged exchange-traded fund (ETF), the Tradr 2X Long TEM Daily ETF (Cboe TEMT). This innovative product aims to provide investors with double the daily performance of shares in Tempus AI, Inc. (Nasdaq: TEM). Tempus AI is at the forefront of transforming healthcare through advanced applications of artificial intelligence, including generative AI technologies focused on precision medicine.

The introduction of the TEMT ETF allows traders who are confident about the potential growth of Tempus AI to benefit from daily stock price fluctuations without the complexities associated with margin trading or options. This product stands out as the first leveraged ETF directly linked to Tempus stock, symbolizing a pioneering step in the field of ETFs.

Background and Context

This launch occurs shortly after Tradr ETFs rolled out two other single-stock leveraged ETFs targeting AppLovin (Nasdaq APP) and D-Wave Quantum (NYSE QBTS). These ETFs, APPX and QBTX, have already attracted considerable investor interest, showcasing steady increases in both assets and trading volumes since their debut. Notably, Tradr ETFs has set a precedent by being the first issuer to release leveraged ETFs tied to individual stocks, beginning with Tesla (TSLQ) and Nvidia (NVDS) back in 2022.

Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs, expressed enthusiasm regarding the launch, stating, "Tempus has significantly accelerated its momentum since its IPO in June 2024, propelled by its unique business model and growth potential. The narrative surrounding Tempus is captivating, driven by an advanced software platform that leverages AI to enhance clinical outcomes and overall patient care. Our ETF allows investors to tap into this innovative space, which many are just beginning to discover."

The Mechanics of the TEMT ETF

The TEMT ETF can be easily traded through standard brokerage accounts, eliminating the typical challenges tied to margin trades and options. Investors opting for this ETF gain access to 10 leveraged products within Tradr's portfolio, further enriching their trading toolkit designed for precision and efficiency.

Leveraged ETFs like TEMT are inherently riskier due to their structure, pursuing amplified results which can result in higher volatility. As highlighted in their official communication, investors are urged to fully comprehend the risks associated with leveraged investments, understanding that significant adverse movements in the underlying stock could result in substantial losses.

In addition to substantial risk, leveraged ETFs are intended for short-term trading purposes. The performance over extended periods may diverge from expected benchmarks, particularly as prices shift daily. Therefore, it's crucial for investors to actively monitor their investments to fully grasp the risks involved.

Conclusion

With this latest ETF launch, Tradr ETFs not only extends its commitment to innovative investment solutions but also marks an exciting chapter within the healthcare technology investment landscape. The Tradr 2X Long TEM Daily ETF is indeed a compelling addition for investors eager to engage with the promising future of artificial intelligence in healthcare.

For comprehensive insights and a thorough understanding of leveraged ETFs and the risks they entail, potential investors can visit www.tradretfs.com for more information. Tradr ETFs remains dedicated to equipping sophisticated investors with cutting-edge tools to effectively articulate their market views.

• ---

Disclaimer: It's important for prospective investors to review the associated risks and strategies before engaging with leveraged ETFs as they carry the potential for greater financial loss.